Michael T. Redman

Michael T. Redman

Chief Executive Officer at
Theratome Bio, Inc.
71 year
Health Technology
Commercial Services
Consumer Services

Profile

Michael T.
Redman
was the founder of Opexa Pharmaceuticals, Inc. (2001) as Chief Executive Officer and Oncolix, Inc. (2006) as Chief Executive Officer & Director.
Mr. Redman is currently the Chief Executive Officer at Theratome Bio, Inc. Former positions include President, Chief Executive Officer, CFO & Director at Advanced Environmental Petroleum Producers, Inc., Chief Executive Officer at Botanix Pharmaceuticals Ltd., Director at Oncolix, Inc. (2006-2019), Principal at Wyeth LLC, Principal at Aronex Pharmaceuticals, Inc., Principal at Repros Therapeutics, Inc., Chief Operating Officer & Executive Vice President at Genprex, Inc. (2019-2021), and Principal at Biovail Pharmaceuticals LLC.
Education includes an undergraduate degree from the University of Missouri and an MBA from the University of Phoenix.

Michael T. Redman active positions

CompaniesPositionStart
Chief Executive Officer -

Former positions of Michael T. Redman

CompaniesPositionEnd
GENPREX, INC. Chief Operating Officer 15/10/2021
ONCOLIX, INC. Chief Executive Officer -
Chief Executive Officer 01/01/2005
Corporate Officer/Principal -
Chief Executive Officer -
See the detail of Michael T. Redman's experience

Training of Michael T. Redman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

8

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael T. Redman